Xenetic Biosciences Inc XBIO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:02 AM EDT
3.84quote price arrow down-0.06 (-1.49%)
Volume
613
52 week range
2.55 - 5.97
Loading...
  • Open3.90
  • Day High4.01
  • Day Low3.84
  • Prev Close3.90
  • 52 Week High5.97
  • 52 Week High Date09/20/23
  • 52 Week Low2.55
  • 52 Week Low Date05/18/23

Key Stats

  • Market Cap5.912M
  • Shares Out1.54M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta2.40
  • YTD % Change16.37

KEY STATS

  • Open3.90
  • Day High4.01
  • Day Low3.84
  • Prev Close3.90
  • 52 Week High5.97
  • 52 Week High Date09/20/23
  • 52 Week Low2.55
  • 52 Week Low Date05/18/23
  • Market Cap5.912M
  • Shares Out1.54M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta2.40
  • YTD % Change16.37

RATIOS/PROFITABILITY

  • EPS (TTM)-2.74
  • P/E (TTM)-1.40
  • Fwd P/E (NTM)-1.99
  • EBITDA (TTM)-4.516M
  • ROE (TTM)-35.28%
  • Revenue (TTM)2.54M
  • Gross Margin (TTM)100.00%
  • Net Margin (TTM)-162.78%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Xenetic Biosciences Inc

 

Content From Our Affiliates

Profile

MORE
Xenetic Biosciences, Inc. is a biopharmaceutical company. The Company is focused on advancing immune-oncology technologies addressing hard to treat cancers. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in cancer progression. It is focused on advancing the development of its DNase platform toward a first-in-human, multicenter, dose...
Adam Logal
Independent Chairman of the Board
Jeffrey Eisenberg
Chief Executive Officer, Director
James Parslow
Chief Financial Officer, Corporate Secretary
Address
945 Concord St.
Framingham, MA
01701
United States

Top Peers

SYMBOLLASTCHG%CHG
SCPX
Scorpius Holdings Inc
0.1746-0.002-1.1129%
OPGN
OpGen Inc
0.459+0.017+3.8462%
ENSC
Ensysce Biosciences Inc
0.555+0.031+5.916%
ARDS
Aridis Pharmaceuticals Inc
0.0625+0.0025+4.1667%
GMDAQ
Gamida Cell Ltd
0.0142+0.0005+3.3577%